SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Invitae Corporation (NVTA) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+51215.8%).
- Analyst consensus target $9.75 (+51215.8% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NVTA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-13.18
Book Value / Share$0.00
Revenue / Share$2.19
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$9.75 (+51215.8%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-1.67 |
$148K |
$-24.84M |
-16782.4% |
| 2014 |
$-1.60 |
$1.6M |
$-47.67M |
-2971.8% |
| 2015 |
$-3.18 |
$8.38M |
$-89.78M |
-1071.6% |
| 2016 |
$-3.02 |
$25.05M |
$-100.26M |
-400.3% |
| 2017 |
$-2.65 |
$68.22M |
$-123.38M |
-180.9% |
| 2018 |
$-1.94 |
$147.7M |
$-129.36M |
-87.6% |
| 2019 |
$-2.66 |
$216.82M |
$-241.97M |
-111.6% |
| 2020 |
$-4.52 |
$279.6M |
$-608.87M |
-217.8% |
| 2021 |
$-1.80 |
$460.45M |
$-379.01M |
-82.3% |
| 2022 |
$-13.18 |
$516.3M |
$-3.11B |
-601.6% |
